Login / Signup

Predictors of predominant Lupus Low Disease Activity State (LLDAS-50).

Hakan BabaogluJ LiD GoldmanL S MagderM Petri
Published in: Lupus (2019)
In this large cohort, only 52.5% achieved LLDAS-50. This proportion was even less in African Americans. A higher percentage of time taking hydroxychloroquine was a modifiable positive predictor of LLDAS-50. Anti-RNP, anti-dsDNA, and low complement were negatively associated with LLDAS-50. Our findings further emphasize the importance of inclusion of African Americans in clinical trials and hydroxychloroquine adherence in both clinical practice and clinical trials.
Keyphrases